While I didn’t need another reason for chalking up 1966 as a vintage year, I quickly found one when I joined Medical Marketing & Media: Not only was 1966 the year in which England won the World Cup, but it also marked the launch of this publication.
The Postgraduate Institute for Medicine (PIM) has hired Jan Schultz, RN, MSN, as director of educational outcomes and accreditation to lead PIM’s new outcomes measurement unit.
A Senate-approved amendment to a Homeland Security Department FY2007 spending bill would allow drugs to be imported into the US by citizens returning from Canada.
FDA drug safety expert, whistleblower Dr. David Graham, has called on FDA officials to pull from the market Sanofi-Aventis’ controversial antibiotic Ketek, saying it is as toxic, “if not more so,” as three other drugs [Rezulin, Trovan and Duract] pulled from the market for liver problems.
The Center for Reproductive Rights asked a federal judge for permission to request e-mails, letters and records of conversations between the FDA and the White House to determine whether the Bush administration gave the agency directions for handling Barr Pharmaceuticals’ OTC switch application for its Plan B emergency contraceptive.
Finance Committee chairman Sen. Chuck Grassley (R-IA) has asked the HHS inspector general to find out how an FDA employee worked “in concert with a pharmaceutical drug maker to discredit the FDA scientist who publicized information about the safety risks of the drug Vioxx.”